Skip to content
healthcare.dev

CIDOFOVIR

NDC 67457-210, Cidofovir Anhydrous, injection, solution, from Mylan Institutional LLC.

Product NDC
67457-210
Status
Listed
Labeler
Mylan Institutional LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201276
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67457-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CIDOFOVIR75 mg/mL

Pharmacologic classes

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]; DNA Polymerase Inhibitors [MoA]; Nucleoside Analog [EXT]

Package NDCNDC-11Package
67457-210-05674570210051 VIAL, GLASS in 1 CARTON (67457-210-05) / 5 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56541229-8c1a-4550-8951-2415ed08e7e9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67457-210

Use it

Look up 67457-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67457-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67457-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.